Search

Home > GRACEcast Lung Cancer Video > ASCO 2012 LC Highlights: Dr. Joel Neal on the SELECT Trial of Tarceva (Erlotinib) As Adjuvant Therapy for EGFR Mutation-Positive Advanced NSCLC (video)
Podcast: GRACEcast Lung Cancer Video
Episode:

ASCO 2012 LC Highlights: Dr. Joel Neal on the SELECT Trial of Tarceva (Erlotinib) As Adjuvant Therapy for EGFR Mutation-Positive Advanced NSCLC (video)
Category: Science & Medicine
Duration: 00:04:51
Publish Date: 2012-09-16 23:11:52
Description:

Dr. Joel Neal summarizes preliminary results of the SELECT trial of adjuvant Tarceva (erlotinib) for patients with resected EGFR mutation-positive early stage non-small cell lung cancer. 
Total Play: 0